HPV in men

Purpose: To collect information about HPV in men and the (possible) correlation with HVP infection in women. Methods: Review of the literature. Results: An overview of HPV-related penile and anal malignancies in men and the risk factors of acquiring HPV. Conclusion: In men HPV is also partially responsible for anogenital malignancies. Although the prevalence of HPV-related malignancies in men is much lower than in women, it is useful to gain more knowlege. Especially knowing if men are really the HPV reservoir and transmitters for women can make a difference in deciding whether men should also be screened for HPV and if they are good candidates for vaccination.

HPV; Male; Penile lesions; Anal lesions; Screening

[1]Dillner J., Meijer C., von Krogh G., Horenblas S.: “Epidemiology of human papillomavirus infection”. Scand. J. Urol. Nephrol. Suppl., 2000, 205, 194.

[2] Koutksy L.: “Epidemiology of genital human papillomavirus infection”. Am. J. Med., 1997, 102, 3.

[3] Gross G., Pfister H.: “Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasia and in genital warts”. Med. Microbiol. Immunol., 2004, 193, 35.

[4] Kjaer S.K., Munk C., Winther J.F., Jorgensen H.O., Meijer C.J., van den Brule A.J.: “Acquisition and persistence of human papillomavirus infection in younger men: a prospective follow-up study among Danish soldiers”. Cancer Epidemiol. Biomarkers Prev., 2006, 14, 1528.

[5] Ikenberg H., Gissmann L., Gross G., Grussendorf-Conen El., zur Hausen H.: “Human papillomavirus type-16-related DNA in genital Bowen’s disease and in bowenoid papulosis”. Int. J. Cancer, 1983, 32, 563.

[6] Cupp M.R., Malek R.S., Goellner J.R., Smith T.F., Espy M.J.: “The detection of human papillomavirus deoxyribonucleic acid in intraepithelial, in situ, verrucous and invasive carcinoma of the penis”. J. Urol., 1995, 154, 1024.

[7] Micali G., Nasca M.R., Innocenzi D., Schwartz R.A.: “Penile cancer”. J. Am. Acad. Dermatol., 2006, 54, 369.

[8] Endo M., Yamashita T., Jin H.-Y., Akutsu Y., Jimbow K.: “Detection of human papillomavirus type 16 in bowenoid papulosis and nonbowenoid tissues”. Int. J. Dermatol., 2003, 42, 474.

[9] Neill S.M., Tatnall F.M., Cox N.H.: “Guidelines for the management of lichen sclerosus”. Br. J. Dermatol., 2002, 147, 640.

[10] Schwarts R.A., Janniger C.K.: “Bowenoid papulosis”. J. Am. Acad. Dermatol., 1991, 24, 261.

[11] Mikhail G.R.: “Cancers, precancers, and pseudocancers on the male genitalia: a review of clinical appearances, histopathology, and management”. J. Dermatol. Surg. Oncol., 1980, 6, 1027.

[12] Lucia M.S., Miller G.J.: “Histopathology of malignant lesions of the penis”. Urol. Clin. North Am., 1992, 19, 227.

[13] Palefsky J.M., Holly E.A., Efirdc J.T., Da Costa M., Jay N., Berry J.M. et al.: “Anal intraepithelial neoplasia in the high active antiretroviral therapy era among HIV-positive men who have sex with men”. AIDS, 2005, 19, 1407.

[14] Maden C., Sherman K.J., Beckmann A.M., Hislop T.G., The C.Z., Ashley R.L. et al.: “History of circumcision, medical conditions, and sexual activity and risk of penile cancer”. J. Invest. Dermatol., 2000, 115, 396.

[15] Rubin M.A., Kleter B., Zhou M., Ayala G., Cubilla A.L., Quint W.G. et al.: “Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis”. Am. J. Pathol., 2001, 159, 1211.

[16] Nasca M.R., Innocenzi D., Micali G.: “Association of penile lichen slerosus and oncogenic human papillomavirus infection”. Int. J. Dermatol., 2006, 45, 681.

[17] Franceschi S., Castellsague X., Dal Maso L., Smith J.S., Plummer M., Ngelangel C. et al.: “Prevalence and determinants of human papillomavirus genital infection in men”. Br. J. Cancer, 2002, 86, 705.

[18] Svare E.I., Kjaer S.J., Worm A.M., Osterlind A., Meijer C.J., van den Brule A.J.: “Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danisch STD clinic”. Sex. Transm. Infect., 2002, 78, 215.

[19] Bleeker M.C.G., Hogewoning C.J.A., Berkhof J., Voorhorst F.J., Hesselink A.T., Van Diemen P.M. et al.: “Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads”. Clin. Infect. Dis., 2005, 41, 612.

[20] Nicolau S.M., Camargo C.G., Stavale J.N., Castelo A., Dôres G.B., Lörincz A. et al.: “Human papillomavirus DNA detection in male sexual partners of women with genital human papillomavirus infection”. Urology, 2005, 65, 251.

[21] Parkin D.M., Wabinga H., Nambooze S., Wabwire-Mangen F.: “AIDS-related cancers in Africa: maturation of the epidemic in Uganda”. AIDS, 1999, 13, 2563.

[22] Piepkorn M., Kumasaka B., Krieger J.N., Burmer G.C.: “Development of human papillomavirus-associated Buschke-Löwenstein penile carcinoma: during cyclosporine therapy for generalized pustular psoriasis”. J. Am. Acad. Dermatol., 1993, 29, 321.

[23] Baldwin S.B., Wallace D.R., Papenfuss M.R., Abrahamsen M., Vaught L.C., Giuliana A.R.: “Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted diseases clinic”. Sex. Transm. Dis., 2004, 31, 601.

[24] Baily R.C., Moses S., Parker C.B., Agot K., MacLean I., Krieger J.N. et al.: “Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomized controlled trial”. Lancet, 2007, 369, 643.

[25] Van Howe R.S.: “Human Papillomavirus and circumcision: a meta-analysis”. J. Infect., 2007, 54, 490.

[26] Tseng H.F., Morgenstern H., Mack T., Peters R.K.: “Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (United States)”. Cancer Causes Control, 2001, 12, 267.

[27] Weaver B.A., Feng Q., Holmes K.K., Kiviat N., Lee S.K., Meyer C. et al.: “Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men”. J. Infect. Dis., 2004, 189, 677.

[28] Hernandez B.Y., McDuffie K., Goodman M.T., Wilkens L.R., Thompson P., Zhu X. et al.: “Comparison of physician- and selfcollected genital specimens for detection of human papillomavirus in men”. J. Clin. Microbiol., 2006, 44, 513.

[29] Fife K.H., Coplan P.M., Jansen K.U., DiCello A.C., Brown D.R., Rojas C. et al.: “Poor sensitivity of polymerase chain reaction assays of genital skin swans and urine to detect HPV 6 and 11 DNA in men”. Sex. Transm. Dis., 2003, 30, 246.

[30] Astori G., Pipan C., Muffato G., Botta G.A.: “Detection of HPVDNA in semen, urine and urethral samples by dot blot and PCR”. New Microbiol., 1995, 18, 143.

[31] Aguilar L.V., Lazcano-Ponce E., Vaccarella S., Cruz A., Hernández P., Smith J.S. et al.: “Human papillomavirus in men: comparison of different genital sites”. Sex. Transm. Infect., 2006, 82, 31.

[32] Rintala M.A.M., Pöllanen P.P., Nikkanen V.P., Grénman S.E., Syrjänen S.M.: “Human papillomavirus DNA is found in the vas deferens”. J. Infect. Dis., 2002, 185, 1664.

[33] D’Hauwers K.W.M., Depuydt C., Bogers J.P., Stalpaert M., Vereecken A., Wyndaele J.J. et al.: “Urine versus brushed samples in HPV-screening. Study in both genders”. Asian J. Andrology, 2007, 9, 705.

[34] Parkin D.M., Wabinga H., Nambooze S., Wabwire-Mangen F.: “AIDS-related cancers in Africa: maturation of the epidemic in Uganda”. AIDS, 1999, 13, 2563.

[35] D’Hauwers K.W.M., Tjalma W.A.A., Depuydt C., Toussaint N., Van de Calsijde S., Vereecken A.J. et al.: “Human papillomavirus infections in women: the potential role of male transmission”. Indian J. Gynaecol. Oncol., 2004, 4, 28.